ORAMED PHARMACEUTICALS INC. (ORMP) Free cash flow 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.2MFY2025 · since FY2016: $4.6M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -8.6% |
| FY2024 | -$8.4M | +20.1% |
| FY2023 | -$10.5M | +62.9% |
| FY2022 | -$28.4M | -31.8% |
| FY2021 | -$21.6M | -72.1% |
| FY2020 | -$12.5M | +3.3% |
| FY2019 | -$13.0M | +11.6% |
| FY2018 | -$14.7M | -151.1% |
| FY2017 | -$5.8M | -225.7% |
| FY2016 | $4.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net incomeORMP Net marginORMP Gross profitORMP Gross marginORMP Operating incomeORMP Operating marginORMP Operating cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Total liabilitiesORMP Shareholders’ equityORMP overview →